Tiziana Life Sciences reports 1H results

Tiziana Life Sciences press release (NASDAQ:TLSA): 1H as of September 2022, the company has a total of 298 granted patents.

For the six months to 30 June 2022 the consolidated Group made a loss of $8.3M (six months to 30 June 2021: $17.0M).

The Group ended the period with $26.5M cash as at 30 June 2022 (31 December 2021: $42.2M).

The company continues to carefully manage its working capital position and continues the process, as referred to below, to evaluate opportunities to raise further funds through the issue of additional equity capital.